Abstract
Arjunolic acid (AA) is a triterpenoid saponin isolated mainly from Terminalia arjuna bark. Arjunolic acid is associated with the various important physiological functions viz. antioxidant, antimicrobial, cardioprotective, hepatoprotective, and plays important role in supramolecular chemistry, etc. Arjunolic acid exhibits important function in maintaining the level of various antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR) and glutathione peroxidase (GPx), level of cellular metabolites, reduced glutathione (GSH), oxidized glutathione (GSSG) and thereby reduces the oxidative stress. Its protective effect on liver, pancreas and kidney has also been the key property of arjunolic acid. Hence, arjunolic acid has potential to treat various disorders and this review may provide valuable information about arjunolic acid.
Keywords: Oxidative stress, arjunolic acid, Terminalia arjuna, reactive oxygen species (ROS), reactive nitrogen species (RON).
Graphical Abstract
Current Organic Chemistry
Title:Arjunolic Acid: A Promising Antioxidant Moiety with Diverse Biological Applications
Volume: 21 Issue: 4
Author(s): Arun Nanda, S. H. Ansari and Sarita Khatkar
Affiliation:
Keywords: Oxidative stress, arjunolic acid, Terminalia arjuna, reactive oxygen species (ROS), reactive nitrogen species (RON).
Abstract: Arjunolic acid (AA) is a triterpenoid saponin isolated mainly from Terminalia arjuna bark. Arjunolic acid is associated with the various important physiological functions viz. antioxidant, antimicrobial, cardioprotective, hepatoprotective, and plays important role in supramolecular chemistry, etc. Arjunolic acid exhibits important function in maintaining the level of various antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR) and glutathione peroxidase (GPx), level of cellular metabolites, reduced glutathione (GSH), oxidized glutathione (GSSG) and thereby reduces the oxidative stress. Its protective effect on liver, pancreas and kidney has also been the key property of arjunolic acid. Hence, arjunolic acid has potential to treat various disorders and this review may provide valuable information about arjunolic acid.
Export Options
About this article
Cite this article as:
Nanda Arun, Ansari H. S. and Khatkar Sarita, Arjunolic Acid: A Promising Antioxidant Moiety with Diverse Biological Applications, Current Organic Chemistry 2017; 21 (4) . https://dx.doi.org/10.2174/1385272820666161017164404
DOI https://dx.doi.org/10.2174/1385272820666161017164404 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alzheimer´s Disease and Oxidative Stress: A Review
Current Medicinal Chemistry Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk
Current Alzheimer Research RNAi Silencing in Mouse Models of Neurodegenerative Diseases
Current Drug Delivery SUBJECT INDEX TO VOLUME 1
Current Genomics Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?
Current Medicinal Chemistry Commentary (Brilliant Blue G: What a Little More Colour Can Be)
CNS & Neurological Disorders - Drug Targets Parkinson’s Disease and Alpha-Synucleinopathies: from Arising Pathways to Therapeutic Challenge
Central Nervous System Agents in Medicinal Chemistry Functional Evaluation of Neural Stem Cell Differentiation by Single Cell Calcium Imaging
Current Stem Cell Research & Therapy Correlation of Alzheimer-like Tau Hyperphosphorylation and fMRI Bold Intensity
Current Alzheimer Research Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools
Current Neuropharmacology Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders
Current Drug Targets Molecular Docking Studies of Methamphetamine and Amphetamine- Related Derivatives as an Inhibitor against Dopamine Receptor
Current Computer-Aided Drug Design Patent Selections
Recent Patents on Biomarkers Monoamine Oxidases: The Biochemistry of the Proteins As Targets in Medicinal Chemistry and Drug Discovery
Current Topics in Medicinal Chemistry Editorial [Hot topic: Prion Diseases: Targets and Treatments of Symptoms and Disease Progression (Guest Editor: Brian Appleby)]
CNS & Neurological Disorders - Drug Targets Editorial (Hot Topic: Glial Proteins and Peptides: Implications in Neuroinflammation)
Current Protein & Peptide Science Disease-Induced Neuroinflammation and Depression
CNS & Neurological Disorders - Drug Targets The Application of Mass Spectrometry to Proteomics and Metabolomics in Biomarker Discovery and Drug Development
Current Molecular Pharmacology